DexCom, Inc. (DXCM)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
28-Aug-14 5:32 PM
View: 
Lord Jonathan T Md
Director
DexCom, Inc. (DXCM) 26-Aug-14Market Option Sale 20,000$45.56$911,240.00(13%)
157.11K to 137.11K
< 1%
27-Aug-14 5:57 PM
View: 
Pacelli Steven Robert
EVP, Strategy & Corp. Dev.
DexCom, Inc. (DXCM) 26-Aug-14Market Option Sale 16,000$44.85$717,523.00(6%)
257.4K to 241.4K
(2%)
28-Aug-14 5:32 PM
View: 
Lord Jonathan T Md
Director
DexCom, Inc. (DXCM) 26-Aug-14Option Exercise 20,000$7.78$155,600.0015%
137.11K to 157.11K
27-Aug-14 5:57 PM
View: 
Pacelli Steven Robert
EVP, Strategy & Corp. Dev.
DexCom, Inc. (DXCM) 26-Aug-14Option Exercise 16,000$20.65$330,400.007%
241.4K to 257.4K
27-Aug-14 5:59 PM
View: 
Balo Andrew K
SVP, Regulatory and Clinical
DexCom, Inc. (DXCM) 25-Aug-14Option Exercise 10,000$7.63$76,300.006%
159.21K to 169.21K
27-Aug-14 5:57 PM
View: 
Pacelli Steven Robert
EVP, Strategy & Corp. Dev.
DexCom, Inc. (DXCM) 25-Aug-14Market Option Sale (Planned) 14,000$44.24$619,338.00(5%)
255.4K to 241.4K
(4%)
27-Aug-14 5:57 PM
View: 
Pacelli Steven Robert
EVP, Strategy & Corp. Dev.
DexCom, Inc. (DXCM) 25-Aug-14Option Exercise 14,000$7.63$106,820.006%
241.4K to 255.4K
27-Aug-14 5:59 PM
View: 
Balo Andrew K
SVP, Regulatory and Clinical
DexCom, Inc. (DXCM) 25-Aug-14Market Option Sale (Planned) 10,000$44.12$441,243.00(6%)
169.21K to 159.21K
(4%)
25-Aug-14 5:13 PM
View: 
Balo Andrew K
SVP, Regulatory and Clinical
DexCom, Inc. (DXCM) 22-Aug-14Option Exercise 20,000$3.19$63,800.0013%
159.21K to 179.21K
25-Aug-14 5:13 PM
View: 
Balo Andrew K
SVP, Regulatory and Clinical
DexCom, Inc. (DXCM) 22-Aug-14Market Option Sale 20,000$44.24$884,722.00(11%)
179.21K to 159.21K
< 1%
14-Aug-14 6:51 PM
View: 
Lister John
Sr. VP, General Counsel
DexCom, Inc. (DXCM) 12-Aug-14Market Option Sale (Planned) 1,750$43.68$76,437.90(2%)
115.91K to 114.16K
< 1%
14-Aug-14 6:51 PM
View: 
Lister John
Sr. VP, General Counsel
DexCom, Inc. (DXCM) 12-Aug-14Market Sale (Planned) 1,603$43.68$70,017.10(1%)
114.16K to 112.56K
< 1%
14-Aug-14 6:51 PM
View: 
Lister John
Sr. VP, General Counsel
DexCom, Inc. (DXCM) 12-Aug-14Option Exercise 1,750$4.58$8,015.002%
114.16K to 115.91K
12-Aug-14 5:44 PM
View: 
Balo Andrew K
SVP, Regulatory and Clinical
DexCom, Inc. (DXCM) 11-Aug-14Market Option Sale (Planned) 10,000$44.24$442,373.00(6%)
169.21K to 159.21K
1%
12-Aug-14 5:44 PM
View: 
Balo Andrew K
SVP, Regulatory and Clinical
DexCom, Inc. (DXCM) 11-Aug-14Option Exercise 10,000$8.94$89,400.006%
159.21K to 169.21K
29-Jul-14 7:07 PM
View: 
Balo Andrew K
SVP, Regulatory and Clinical
DexCom, Inc. (DXCM) 25-Jul-14Option Exercise 10,000$8.94$89,400.006%
159.1K to 169.1K
29-Jul-14 7:07 PM
View: 
Balo Andrew K
SVP, Regulatory and Clinical
DexCom, Inc. (DXCM) 25-Jul-14Market Option Sale (Planned) 10,000$38.19$381,857.00(6%)
169.1K to 159.1K
(14%)
24-Jul-14 5:49 PM
View: 
Pacelli Steven Robert
EVP, Strategy & Corp. Dev.
DexCom, Inc. (DXCM) 23-Jul-14Market Option Sale (Planned) 14,000$38.28$535,986.00(5%)
255.4K to 241.4K
(14%)
24-Jul-14 5:49 PM
View: 
Pacelli Steven Robert
EVP, Strategy & Corp. Dev.
DexCom, Inc. (DXCM) 23-Jul-14Option Exercise 14,000$7.63$106,820.006%
241.4K to 255.4K
15-Jul-14 6:46 PM
View: 
Lister John
Sr. VP, General Counsel
DexCom, Inc. (DXCM) 14-Jul-14Option Exercise 1,750$4.58$8,015.002%
115.91K to 117.66K
15-Jul-14 6:46 PM
View: 
Lister John
Sr. VP, General Counsel
DexCom, Inc. (DXCM) 14-Jul-14Market Option Sale (Planned) 1,750$36.59$64,038.40(1%)
117.66K to 115.91K
(19%)
15-Jul-14 6:46 PM
View: 
Lister John
Sr. VP, General Counsel
DexCom, Inc. (DXCM) 14-Jul-14Market Sale (Planned) 1,750$36.59$64,038.40(2%)
115.91K to 114.16K
(19%)
15-Jul-14 6:45 PM
View: 
Balo Andrew K
SVP, Regulatory and Clinical
DexCom, Inc. (DXCM) 11-Jul-14Market Option Sale (Planned) 10,000$35.93$359,347.00(6%)
169.1K to 159.1K
(21%)
15-Jul-14 6:45 PM
View: 
Balo Andrew K
SVP, Regulatory and Clinical
DexCom, Inc. (DXCM) 11-Jul-14Option Exercise 10,000$8.94$89,400.006%
159.1K to 169.1K
03-Jul-14 4:34 PM
View: 
Skyler Jay S
Director
DexCom, Inc. (DXCM) 02-Jul-14Market Sale (Planned) 12,200$40.09$489,115.00(8%)
154.97K to 142.77K
(9%)
03-Jul-14 4:34 PM
View: 
Skyler Jay S
Director
DexCom, Inc. (DXCM) 01-Jul-14Market Sale (Planned) 17,800$40.02$712,290.00(10%)
172.77K to 154.97K
(9%)
25-Jun-14 8:35 PM
View: 
Balo Andrew K
SVP, Regulatory and Clinical
DexCom, Inc. (DXCM) 25-Jun-14Option Exercise 10,000$8.94$89,400.006%
159.1K to 169.1K
25-Jun-14 8:35 PM
View: 
Balo Andrew K
SVP, Regulatory and Clinical
DexCom, Inc. (DXCM) 25-Jun-14Market Option Sale (Planned) 10,000$40.60$405,982.00(6%)
169.1K to 159.1K
(7%)
25-Jun-14 8:34 PM
View: 
Pacelli Steven Robert
EVP, Strategy & Corp. Dev.
DexCom, Inc. (DXCM) 23-Jun-14Market Option Sale (Planned) 14,000$41.02$574,235.00(5%)
255.4K to 241.4K
(6%)
25-Jun-14 8:34 PM
View: 
Pacelli Steven Robert
EVP, Strategy & Corp. Dev.
DexCom, Inc. (DXCM) 23-Jun-14Option Exercise 14,000$7.45$104,326.006%
241.4K to 255.4K
23-Jun-14 6:10 PM
View: 
Skyler Jay S
Director
DexCom, Inc. (DXCM) 20-Jun-14Market Sale (Planned) 30,000$40.00$1,200,000.00(15%)
202.77K to 172.77K
(9%)
23-Jun-14 6:10 PM
View: 
Skyler Jay S
Director
DexCom, Inc. (DXCM) 19-Jun-14Market Sale (Planned) 30,000$40.00$1,200,000.00(13%)
232.77K to 202.77K
(9%)
13-Jun-14 5:01 PM
View: 
Lister John
Sr. VP, General Counsel
DexCom, Inc. (DXCM) 12-Jun-14Market Option Sale (Planned) 1,750$36.13$63,227.50(1%)
119.41K to 117.66K
(21%)
13-Jun-14 5:01 PM
View: 
Lister John
Sr. VP, General Counsel
DexCom, Inc. (DXCM) 12-Jun-14Option Exercise 1,750$4.58$8,015.001%
117.66K to 119.41K
13-Jun-14 5:01 PM
View: 
Lister John
Sr. VP, General Counsel
DexCom, Inc. (DXCM) 12-Jun-14Market Sale (Planned) 1,750$36.13$63,227.50(1%)
117.66K to 115.91K
(21%)
13-Jun-14 4:58 PM
View: 
Balo Andrew K
SVP, Regulatory and Clinical
DexCom, Inc. (DXCM) 11-Jun-14Option Exercise 10,000$8.94$89,400.006%
159.1K to 169.1K
13-Jun-14 4:58 PM
View: 
Balo Andrew K
SVP, Regulatory and Clinical
DexCom, Inc. (DXCM) 11-Jun-14Market Option Sale (Planned) 10,000$36.63$366,305.00(6%)
169.1K to 159.1K
(19%)
03-Jun-14 7:35 PM
View: 
Lord Jonathan T Md
Director
DexCom, Inc. (DXCM) 30-May-14Grant 8,797$0.00$8.807%
128.31K to 137.11K
03-Jun-14 7:34 PM
View: 
Skyler Jay S
Director
DexCom, Inc. (DXCM) 30-May-14Grant 6,887$0.00$6.893%
225.88K to 232.77K
03-Jun-14 7:35 PM
View: 
Augustinos Nicholas
Director
DexCom, Inc. (DXCM) 30-May-14Grant 6,462$0.00$6.4658%
11.13K to 17.59K
28-May-14 7:45 PM
View: 
Balo Andrew K
SVP, Regulatory and Clinical
DexCom, Inc. (DXCM) 27-May-14Option Exercise 10,000$7.25$72,500.006%
159.1K to 169.1K
28-May-14 7:45 PM
View: 
Balo Andrew K
SVP, Regulatory and Clinical
DexCom, Inc. (DXCM) 27-May-14Market Option Sale (Planned) 10,000$33.86$338,638.00(6%)
169.1K to 159.1K
(31%)
28-May-14 7:55 PM
View: 
Pacelli Steven Robert
EVP, Strategy & Corp. Dev.
DexCom, Inc. (DXCM) 23-May-14Market Option Sale (Planned) 14,000$32.76$458,632.00(5%)
255.4K to 241.4K
(33%)
28-May-14 7:55 PM
View: 
Pacelli Steven Robert
EVP, Strategy & Corp. Dev.
DexCom, Inc. (DXCM) 23-May-14Option Exercise 14,000$7.25$101,500.006%
241.4K to 255.4K
14-May-14 4:52 PM
View: 
Balo Andrew K
SVP, Regulatory and Clinical
DexCom, Inc. (DXCM) 12-May-14Option Exercise 10,000$7.25$72,500.006%
159.1K to 169.1K
14-May-14 4:50 PM
View: 
Lister John
Sr. VP, General Counsel
DexCom, Inc. (DXCM) 12-May-14Option Exercise 1,750$4.58$8,015.001%
119.41K to 121.16K
14-May-14 4:50 PM
View: 
Lister John
Sr. VP, General Counsel
DexCom, Inc. (DXCM) 12-May-14Market Option Sale (Planned) 1,750$31.52$55,160.00(1%)
121.16K to 119.41K
(38%)
14-May-14 4:52 PM
View: 
Balo Andrew K
SVP, Regulatory and Clinical
DexCom, Inc. (DXCM) 12-May-14Market Option Sale (Planned) 10,000$31.75$317,499.00(6%)
169.1K to 159.1K
(37%)
14-May-14 4:50 PM
View: 
Lister John
Sr. VP, General Counsel
DexCom, Inc. (DXCM) 12-May-14Market Sale (Planned) 1,750$31.52$55,160.00(1%)
119.41K to 117.66K
(38%)
29-Apr-14 5:04 PM
View: 
Balo Andrew K
SVP, Regulatory and Clinical
DexCom, Inc. (DXCM) 25-Apr-14Market Option Sale (Planned) 10,000$34.35$343,460.00(6%)
169.1K to 159.1K
(27%)